VANCOUVER, British Columbia, Feb. 2022 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global health technology company that has developed a platform for next-generation AI to help patients and caregivers around the world make better healthcare decisions.
After a successful launch on the Apple App Store, Treatment’s breakthrough symptom assessment tool, Treatment Digital Health App, is now available to millions of smartphone users through the Google Play Store. Powered by Treatment’s proprietary medical AI engine and groundbreaking Global Library of Medicine (GLM), the Treatment Digital Health App provides the most advanced access to medical knowledge ever available for widespread use.
“We were delighted to receive overwhelmingly positive reviews on the Apple App Store for our very first product launch, including from qualified sources such as doctors. With so many global users accessing information via Samsung Galaxy smartphones and other digital products, we are confident that this launch on the Google Play Store will go a long way in meeting the growing global need for up-to-date and credible health information,” said John Fraser, CEO of Treatment.
the Treatment Digital Health App health ratings go beyond what users might find through a typical online search, as results are generated using up-to-date estimates of disease rates, current estimates of geographic variation and the latest medical research. Physicians around the world currently rely on Treatment’s AI software to provide insights for their clinical assessments, and the same technology is used by leading medical schools to test students’ clinical skills. Now even more users will have access to the same revolutionary technology thanks to the Treatment Digital Health App.
At the heart of the Treatment Digital Health App sits Treatment’s innovative Global Library of Medicine (GLM) and its powerful AI engine – together they form an advanced and scalable medical intelligence platform providing global diagnostics and treatment protocols that can be adapted to meet local needs. “Our comprehensive symptom assessment process is unlike anything else on the market and is a sign of the innovative products on Treatment’s 2022 product launch plan,” says Dr. Paul A. Markham, Director of treatment strategy. “With this launch on the Google Play Store, the Treatment Digital Health App will be available to millions more potential users looking for a way to manage their health in what has become the COVID era of healthcare,” said Dr Markham.
the Treatment Digital Health App is available worldwide on the Apple App Store and Google Play Store.
Treatment.com is a disruptive health technology company that harnesses the power of AI to help global citizens improve their health through personalized recommendations and insights. Based in Vancouver with a US subsidiary, the company has spent the past five years working with a team of world-class doctors, engineers, mathematicians and AI specialists to develop a sophisticated and scalable AI engine. that leverages the most robust personalized data to generate highly predictive and accurate insights. Treatment.com is the company behind the new version of the Treatment Digital Health App. This doctor-designed app is driven by a smart digital health assistant that will allow people to take control of their health. Physicians are encouraged to apply for NFT and blockchain rewards for contributing to Treatment’s growing compendium of medical knowledge housed in its exclusive Global Library of Medicine.
For more information about Treatment.com, visit https://treatment.com/investors/.
This press release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by words such as “will”, “may”, “should”, “anticipate”, “expect” and similar expressions. All statements, other than statements of historical fact, included in this release, including, without limitation, statements regarding Treatment’s future plans and goals, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment’s expectations include other risks detailed from time to time in Treatment’s filings with securities regulators.
Readers are cautioned that the assumptions used in preparing any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those anticipated due to numerous known and unknown risks, uncertainties and other factors, many of which are beyond Treatment’s control. Readers are cautioned not to place undue reliance on forward-looking information. Such information, although considered reasonable by management when prepared, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this press release are expressly qualified by this cautionary statement. The forward-looking statements contained in this press release are made as of the date of this press release, and Treatment will not publicly update or revise any forward-looking statements included herein except as expressly required by Canadian securities law.
For more information:
Contact with investors: [email protected]